To the best of our knowledge, ours is the first study to report that YAP1 directly transcriptionally regulates ABCG2, a major multidrug transporter implicated in lung cancer, and that deactivation of YAP1 efficiently eliminates SP cells in lung cancer cells. Here, ABCG2 is linked to lung carcinoma.